Global Age-related Macular Degeneration Supply, Demand and Key Producers, 2024-2030

Page: 112

Published Date: 09 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Age-related Macular Degeneration market size is expected to reach $ 11600 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

This report studies the global Age-related Macular Degeneration demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Age-related Macular Degeneration, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Age-related Macular Degeneration that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Age-related Macular Degeneration total market, 2019-2030, (USD Million)
Global Age-related Macular Degeneration total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Age-related Macular Degeneration total market, key domestic companies and share, (USD Million)
Global Age-related Macular Degeneration revenue by player and market share 2019-2024, (USD Million)
Global Age-related Macular Degeneration total market by Type, CAGR, 2019-2030, (USD Million)
Global Age-related Macular Degeneration total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Age-related Macular Degeneration market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb and Gilead Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Age-related Macular Degeneration market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Age-related Macular Degeneration Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Age-related Macular Degeneration Market, Segmentation by Type
Wet AMD
Dry AMD

Global Age-related Macular Degeneration Market, Segmentation by Application
Drugstore
Hospital
Others

Companies Profiled:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical

Key Questions Answered
1. How big is the global Age-related Macular Degeneration market?
2. What is the demand of the global Age-related Macular Degeneration market?
3. What is the year over year growth of the global Age-related Macular Degeneration market?
4. What is the total value of the global Age-related Macular Degeneration market?
5. Who are the major players in the global Age-related Macular Degeneration market?

Table of Contents

1 Supply Summary
    1.1 Age-related Macular Degeneration Introduction
    1.2 World Age-related Macular Degeneration Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Age-related Macular Degeneration Total Market by Region (by Headquarter Location)
        1.3.1 World Age-related Macular Degeneration Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Age-related Macular Degeneration Market Size (2019-2030)
        1.3.3 China Age-related Macular Degeneration Market Size (2019-2030)
        1.3.4 Europe Age-related Macular Degeneration Market Size (2019-2030)
        1.3.5 Japan Age-related Macular Degeneration Market Size (2019-2030)
        1.3.6 South Korea Age-related Macular Degeneration Market Size (2019-2030)
        1.3.7 ASEAN Age-related Macular Degeneration Market Size (2019-2030)
        1.3.8 India Age-related Macular Degeneration Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Age-related Macular Degeneration Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Age-related Macular Degeneration Major Market Trends

2 Demand Summary
    2.1 World Age-related Macular Degeneration Consumption Value (2019-2030)
    2.2 World Age-related Macular Degeneration Consumption Value by Region
        2.2.1 World Age-related Macular Degeneration Consumption Value by Region (2019-2024)
        2.2.2 World Age-related Macular Degeneration Consumption Value Forecast by Region (2025-2030)
    2.3 United States Age-related Macular Degeneration Consumption Value (2019-2030)
    2.4 China Age-related Macular Degeneration Consumption Value (2019-2030)
    2.5 Europe Age-related Macular Degeneration Consumption Value (2019-2030)
    2.6 Japan Age-related Macular Degeneration Consumption Value (2019-2030)
    2.7 South Korea Age-related Macular Degeneration Consumption Value (2019-2030)
    2.8 ASEAN Age-related Macular Degeneration Consumption Value (2019-2030)
    2.9 India Age-related Macular Degeneration Consumption Value (2019-2030)

3 World Age-related Macular Degeneration Companies Competitive Analysis
    3.1 World Age-related Macular Degeneration Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Age-related Macular Degeneration Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Age-related Macular Degeneration in 2023
        3.2.3 Global Concentration Ratios (CR8) for Age-related Macular Degeneration in 2023
    3.3 Age-related Macular Degeneration Company Evaluation Quadrant
    3.4 Age-related Macular Degeneration Market: Overall Company Footprint Analysis
        3.4.1 Age-related Macular Degeneration Market: Region Footprint
        3.4.2 Age-related Macular Degeneration Market: Company Product Type Footprint
        3.4.3 Age-related Macular Degeneration Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Age-related Macular Degeneration Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Age-related Macular Degeneration Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Age-related Macular Degeneration Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Age-related Macular Degeneration Consumption Value Comparison
        4.2.1 United States VS China: Age-related Macular Degeneration Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Age-related Macular Degeneration Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Age-related Macular Degeneration Companies and Market Share, 2019-2024
        4.3.1 United States Based Age-related Macular Degeneration Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Age-related Macular Degeneration Revenue, (2019-2024)
    4.4 China Based Companies Age-related Macular Degeneration Revenue and Market Share, 2019-2024
        4.4.1 China Based Age-related Macular Degeneration Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Age-related Macular Degeneration Revenue, (2019-2024)
    4.5 Rest of World Based Age-related Macular Degeneration Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Age-related Macular Degeneration Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Age-related Macular Degeneration Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Age-related Macular Degeneration Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Wet AMD
        5.2.2 Dry AMD
    5.3 Market Segment by Type
        5.3.1 World Age-related Macular Degeneration Market Size by Type (2019-2024)
        5.3.2 World Age-related Macular Degeneration Market Size by Type (2025-2030)
        5.3.3 World Age-related Macular Degeneration Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Age-related Macular Degeneration Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Drugstore
        6.2.2 Hospital
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Age-related Macular Degeneration Market Size by Application (2019-2024)
        6.3.2 World Age-related Macular Degeneration Market Size by Application (2025-2030)
        6.3.3 World Age-related Macular Degeneration Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bayer HealthCare
        7.1.1 Bayer HealthCare Details
        7.1.2 Bayer HealthCare Major Business
        7.1.3 Bayer HealthCare Age-related Macular Degeneration Product and Services
        7.1.4 Bayer HealthCare Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer HealthCare Recent Developments/Updates
        7.1.6 Bayer HealthCare Competitive Strengths & Weaknesses
    7.2 F. Hoffmann-La Roche
        7.2.1 F. Hoffmann-La Roche Details
        7.2.2 F. Hoffmann-La Roche Major Business
        7.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Product and Services
        7.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 F. Hoffmann-La Roche Recent Developments/Updates
        7.2.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Age-related Macular Degeneration Product and Services
        7.3.4 Novartis Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Regeneron Pharmaceuticals
        7.4.1 Regeneron Pharmaceuticals Details
        7.4.2 Regeneron Pharmaceuticals Major Business
        7.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Services
        7.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Regeneron Pharmaceuticals Recent Developments/Updates
        7.4.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Alcon
        7.5.1 Alcon Details
        7.5.2 Alcon Major Business
        7.5.3 Alcon Age-related Macular Degeneration Product and Services
        7.5.4 Alcon Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Alcon Recent Developments/Updates
        7.5.6 Alcon Competitive Strengths & Weaknesses
    7.6 Allergan
        7.6.1 Allergan Details
        7.6.2 Allergan Major Business
        7.6.3 Allergan Age-related Macular Degeneration Product and Services
        7.6.4 Allergan Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Allergan Recent Developments/Updates
        7.6.6 Allergan Competitive Strengths & Weaknesses
    7.7 Avalanche
        7.7.1 Avalanche Details
        7.7.2 Avalanche Major Business
        7.7.3 Avalanche Age-related Macular Degeneration Product and Services
        7.7.4 Avalanche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Avalanche Recent Developments/Updates
        7.7.6 Avalanche Competitive Strengths & Weaknesses
    7.8 Bausch+Lomb
        7.8.1 Bausch+Lomb Details
        7.8.2 Bausch+Lomb Major Business
        7.8.3 Bausch+Lomb Age-related Macular Degeneration Product and Services
        7.8.4 Bausch+Lomb Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Bausch+Lomb Recent Developments/Updates
        7.8.6 Bausch+Lomb Competitive Strengths & Weaknesses
    7.9 Gilead Sciences
        7.9.1 Gilead Sciences Details
        7.9.2 Gilead Sciences Major Business
        7.9.3 Gilead Sciences Age-related Macular Degeneration Product and Services
        7.9.4 Gilead Sciences Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Gilead Sciences Recent Developments/Updates
        7.9.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.10 Iconic Therapeutics
        7.10.1 Iconic Therapeutics Details
        7.10.2 Iconic Therapeutics Major Business
        7.10.3 Iconic Therapeutics Age-related Macular Degeneration Product and Services
        7.10.4 Iconic Therapeutics Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Iconic Therapeutics Recent Developments/Updates
        7.10.6 Iconic Therapeutics Competitive Strengths & Weaknesses
    7.11 Neurotech Pharmaceuticals
        7.11.1 Neurotech Pharmaceuticals Details
        7.11.2 Neurotech Pharmaceuticals Major Business
        7.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Services
        7.11.4 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Neurotech Pharmaceuticals Recent Developments/Updates
        7.11.6 Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Ohr Pharmaceutical
        7.12.1 Ohr Pharmaceutical Details
        7.12.2 Ohr Pharmaceutical Major Business
        7.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Product and Services
        7.12.4 Ohr Pharmaceutical Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Ohr Pharmaceutical Recent Developments/Updates
        7.12.6 Ohr Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Age-related Macular Degeneration Industry Chain
    8.2 Age-related Macular Degeneration Upstream Analysis
    8.3 Age-related Macular Degeneration Midstream Analysis
    8.4 Age-related Macular Degeneration Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Age-related Macular Degeneration Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Age-related Macular Degeneration Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Age-related Macular Degeneration Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Age-related Macular Degeneration Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Age-related Macular Degeneration Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Age-related Macular Degeneration Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Age-related Macular Degeneration Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Age-related Macular Degeneration Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Age-related Macular Degeneration Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Age-related Macular Degeneration Players in 2023
    Table 12. World Age-related Macular Degeneration Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Age-related Macular Degeneration Company Evaluation Quadrant
    Table 14. Head Office of Key Age-related Macular Degeneration Player
    Table 15. Age-related Macular Degeneration Market: Company Product Type Footprint
    Table 16. Age-related Macular Degeneration Market: Company Product Application Footprint
    Table 17. Age-related Macular Degeneration Mergers & Acquisitions Activity
    Table 18. United States VS China Age-related Macular Degeneration Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Age-related Macular Degeneration Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Age-related Macular Degeneration Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Age-related Macular Degeneration Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Age-related Macular Degeneration Revenue Market Share (2019-2024)
    Table 23. China Based Age-related Macular Degeneration Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Age-related Macular Degeneration Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Age-related Macular Degeneration Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Age-related Macular Degeneration Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Age-related Macular Degeneration Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Age-related Macular Degeneration Revenue Market Share (2019-2024)
    Table 29. World Age-related Macular Degeneration Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Age-related Macular Degeneration Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Age-related Macular Degeneration Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Age-related Macular Degeneration Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Age-related Macular Degeneration Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Age-related Macular Degeneration Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bayer HealthCare Basic Information, Area Served and Competitors
    Table 36. Bayer HealthCare Major Business
    Table 37. Bayer HealthCare Age-related Macular Degeneration Product and Services
    Table 38. Bayer HealthCare Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bayer HealthCare Recent Developments/Updates
    Table 40. Bayer HealthCare Competitive Strengths & Weaknesses
    Table 41. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
    Table 42. F. Hoffmann-La Roche Major Business
    Table 43. F. Hoffmann-La Roche Age-related Macular Degeneration Product and Services
    Table 44. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. F. Hoffmann-La Roche Recent Developments/Updates
    Table 46. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Age-related Macular Degeneration Product and Services
    Table 50. Novartis Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Novartis Competitive Strengths & Weaknesses
    Table 53. Regeneron Pharmaceuticals Basic Information, Area Served and Competitors
    Table 54. Regeneron Pharmaceuticals Major Business
    Table 55. Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Services
    Table 56. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 58. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    Table 59. Alcon Basic Information, Area Served and Competitors
    Table 60. Alcon Major Business
    Table 61. Alcon Age-related Macular Degeneration Product and Services
    Table 62. Alcon Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Alcon Recent Developments/Updates
    Table 64. Alcon Competitive Strengths & Weaknesses
    Table 65. Allergan Basic Information, Area Served and Competitors
    Table 66. Allergan Major Business
    Table 67. Allergan Age-related Macular Degeneration Product and Services
    Table 68. Allergan Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Allergan Recent Developments/Updates
    Table 70. Allergan Competitive Strengths & Weaknesses
    Table 71. Avalanche Basic Information, Area Served and Competitors
    Table 72. Avalanche Major Business
    Table 73. Avalanche Age-related Macular Degeneration Product and Services
    Table 74. Avalanche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Avalanche Recent Developments/Updates
    Table 76. Avalanche Competitive Strengths & Weaknesses
    Table 77. Bausch+Lomb Basic Information, Area Served and Competitors
    Table 78. Bausch+Lomb Major Business
    Table 79. Bausch+Lomb Age-related Macular Degeneration Product and Services
    Table 80. Bausch+Lomb Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Bausch+Lomb Recent Developments/Updates
    Table 82. Bausch+Lomb Competitive Strengths & Weaknesses
    Table 83. Gilead Sciences Basic Information, Area Served and Competitors
    Table 84. Gilead Sciences Major Business
    Table 85. Gilead Sciences Age-related Macular Degeneration Product and Services
    Table 86. Gilead Sciences Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Gilead Sciences Recent Developments/Updates
    Table 88. Gilead Sciences Competitive Strengths & Weaknesses
    Table 89. Iconic Therapeutics Basic Information, Area Served and Competitors
    Table 90. Iconic Therapeutics Major Business
    Table 91. Iconic Therapeutics Age-related Macular Degeneration Product and Services
    Table 92. Iconic Therapeutics Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Iconic Therapeutics Recent Developments/Updates
    Table 94. Iconic Therapeutics Competitive Strengths & Weaknesses
    Table 95. Neurotech Pharmaceuticals Basic Information, Area Served and Competitors
    Table 96. Neurotech Pharmaceuticals Major Business
    Table 97. Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Services
    Table 98. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Neurotech Pharmaceuticals Recent Developments/Updates
    Table 100. Ohr Pharmaceutical Basic Information, Area Served and Competitors
    Table 101. Ohr Pharmaceutical Major Business
    Table 102. Ohr Pharmaceutical Age-related Macular Degeneration Product and Services
    Table 103. Ohr Pharmaceutical Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 104. Global Key Players of Age-related Macular Degeneration Upstream (Raw Materials)
    Table 105. Age-related Macular Degeneration Typical Customers
List of Figure
    Figure 1. Age-related Macular Degeneration Picture
    Figure 2. World Age-related Macular Degeneration Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Age-related Macular Degeneration Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Age-related Macular Degeneration Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Age-related Macular Degeneration Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Age-related Macular Degeneration Revenue (2019-2030) & (USD Million)
    Figure 13. Age-related Macular Degeneration Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Age-related Macular Degeneration Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Age-related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Age-related Macular Degeneration by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Age-related Macular Degeneration Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Age-related Macular Degeneration Markets in 2023
    Figure 27. United States VS China: Age-related Macular Degeneration Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Age-related Macular Degeneration Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Age-related Macular Degeneration Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Age-related Macular Degeneration Market Size Market Share by Type in 2023
    Figure 31. Wet AMD
    Figure 32. Dry AMD
    Figure 33. World Age-related Macular Degeneration Market Size Market Share by Type (2019-2030)
    Figure 34. World Age-related Macular Degeneration Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Age-related Macular Degeneration Market Size Market Share by Application in 2023
    Figure 36. Drugstore
    Figure 37. Hospital
    Figure 38. Others
    Figure 39. Age-related Macular Degeneration Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical

Related Reports

Global Age-related Macular Degeneration Supply, Demand and Key Producers, 2023-2029

Global Age-related Macular Degeneration Supply, Demand and Key Producers, 2023-2029

date 15 Jan 2023

date Medical Care

This report studies the global Age-related Macular Degeneration demand, key companies, and key regions.

Global Age-related Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Age-related Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Age-related Macular Degeneration market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.

Product Tags

Age Related Macular Degeneration Drug

Age-related Macular Degeneration

Age Related Macular Degeneration Drugs

Dry Age-Related Macular Degeneration

Ophthalmology for Age-related Macular Degeneration Diseases

Age Related Macular Degeneration (AMD)

Gene Therapy for Age-related Macular Degeneration

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>